Multiple Assemblies exist for SMTL entry 5lr6
Crystal Structure of COMT in complex with [3-(2,4-dimethyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]-(4-phenylpiperazin-1-yl)methanone; X-RAY DIFFRACTION 2.30 Å

	SMTL ID 5lr6.1 Ligands [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone; 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID; CHLORIDE ION Polypeptides Catechol O-methyltransferase Oligo-state monomer
	SMTL ID 5lr6.2 Ligands [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone; 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID; CHLORIDE ION Polypeptides Catechol O-methyltransferase Oligo-state monomer
	SMTL ID 5lr6.3 Ligands 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID; [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone; CHLORIDE ION Polypeptides Catechol O-methyltransferase Oligo-state monomer
	SMTL ID 5lr6.4 Ligands [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone; 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID; CHLORIDE ION Polypeptides Catechol O-methyltransferase Oligo-state monomer